)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
PeptiDream
PeptiDream (4587) investor relations material
PeptiDream Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary16 Feb, 2026
Executive summary
Transitioned from a discovery-focused start-up to a global pharmaceutical company with a robust pipeline in macrocyclic peptide therapeutics and radiopharmaceuticals, ending FY2025 with 13 clinical programs, nearly doubling from the previous year.
Maintained profitability in radiopharmaceuticals for the fourth consecutive year, but overall FY2025 revenue was significantly below forecast due to delayed out-licensing and milestone deals, resulting in a net loss of ¥3.7 billion.
Management structure expanded and major investments initiated in R&D and manufacturing facilities to support future growth.
No dividends paid or planned, with a focus on R&D investment and internal reserves.
Financial highlights
FY2025 revenue was ¥18.5 billion, down 60.3% YoY and significantly below the initial forecast, mainly due to delayed out-licensing; radiopharmaceuticals contributed ¥15.7 billion, drug discovery ¥2.8 billion.
EBITDA was negative at ¥2.8 billion; net loss attributable to owners was ¥3.7 billion; basic EPS was -¥28.99.
Cash and cash equivalents ended at ¥28.7 billion, down ¥19.4 billion YoY.
R&D expenses to increase from ¥5 billion in 2025 to ¥6.5 billion in 2026.
FY2026 revenue forecast is ¥32 billion plus potential large upfront payments, with core operating profit expected at ¥4.6 billion.
Outlook and guidance
Anticipates 6–12 new clinical programs to enter development in 2026, targeting 19–25 programs by year-end.
Conservative revenue guidance for 2026, separating high-probability projects (¥15 billion) from potential large lump-sum deals.
Long-term goal to reach ¥100 billion in annual revenue, driven by core therapeutic areas.
R&D spending and headcount expected to rise as more programs advance.
What underpins the FY2026 revenue forecast growth?
Which wholly-owned programs enter clinical trials in 2026?
How is governance reinforced post-reagent incident?
Oral myostatin inhibitor partnering strategy
PDRadiopharma's Japan rights strategy
FY2026 revenue stabilization strategy
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next PeptiDream earnings date
Q1 202612 May, 2026
PeptiDream
Next PeptiDream earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
PeptiDream Inc. is a Japan-based biotechnology company specializing in peptide-based drug discovery and development. The company utilizes its proprietary Peptide Discovery Platform System (PDPS) to identify and optimize peptide therapeutics for various medical applications. PeptiDream collaborates with global pharmaceutical companies to develop novel therapeutics across multiple disease areas. Its research and development efforts focus on peptide-drug conjugates, small-molecule drugs, and peptide-based imaging agents. The company is headquartered in Kawasaki, Japan, and its shares are listed on the TSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage